Timothy Stanley: Doctor lespater, there's a really interesting story playing out in the equity market right now. You have shares of madurna under pressure, down 12 % on this news. Do you think that fewer people will get vaccinated, because that's part of the thesis as to why maderna shares are down? He says i don't think so. Maderna ath moran technology is not just for cob and may be useful for ritin cancers, other viruses. So i think it's probably an overly action on both stocks, quite frankly.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode